BAT Tests Find Overfilled E-Cigarette Liquids in UK Market

Mar.17.2023
BAT Tests Find Overfilled E-Cigarette Liquids in UK Market
A test by BAT found most major disposable e-cigarette brands in the UK have overfilled e-liquid, according to betterRetailing.

On March 17th, UK media outlet betterRetailing released a report on BAT (British American Tobacco) testing, which revealed that almost all major disposable e-cigarette brands in the UK had exceeded the legal limit for nicotine content in their e-liquids. This included popular UK brands such as Elfbar, LOSTMARY, SMOK, SKE Crystal, and Solo. BAT sent the results of the testing report to distributors, retailers, and regulatory bodies, urging them to ensure that non-compliant products were not supplied.


The President of UKVIA, John...


In response to this incident, 2FIRSTS conducted an email interview with the President of the UK Vaping Industry Association (UKVIA), John. The original interview in English can be accessed by clicking the provided link. The following is the full transcript of the interview.


Can you provide the English translation of "Q:2FIRSTS"? It is unclear what you are referring to.


A spokesperson for the UK Vaping Industry Association (UKVIA), John


According to a report from Better Retailing, British American Tobacco conducted testing on disposable e-cigarette liquid in the UK market and sent the results to distributors and government departments. Has the association been made aware of this news? Did British American Tobacco send the testing report to the association?


BAT has conducted numerous tests on disposable e-cigarette brands in the UK and shared its findings with various organizations, including the association. It is also known that other companies have conducted similar tests, but their results differ from those of BAT.


Do you believe that the issue of "e-cigarette e-liquid exceeding standards" is a common problem in the UK e-cigarette market?


A: Yes, based on the data we have seen, we do believe that some brands have been using excessive amounts of e-liquid to gain a competitive advantage.


Question: Will this test result regarding the excessive levels found in disposable e-cigarettes have an impact on the disposable e-cigarette market in the UK?


A: Yes, I believe this highlights issues with the MHRA approval process. I expect this process to become more rigorous. Additionally, I think major distributors should now perform their own testing on products they bring in. Non-compliant behavior is unacceptable.


Several brand dealers have said that some of the products tested by BAT are "old inventory," while the latest products are now compliant with standards. Will UKVIA test the latest products?


A: The key issue is not the inventory itself, as "old stock" is not a legitimate excuse. In fact, it's quite simple - products are either compliant or non-compliant. I believe all brands should conduct regular testing to ensure they are following the rules. The association will not protect those who break the law.


Q: Has BAT been in contact with the association and asked them to take measures?


Yes, we have had multiple discussions with BAT regarding this issue. If the MHRA and trade transaction standards are the regulators and enforcers in this matter, we will work with both institutions to ensure that the products sold in the UK are legal. The association will also protect its good reputation.


Special Statement: The above content is a translated article, for accurate interpretation please refer to the original English version.


Click here to read the original article in English: UKVIA responds to overfill incident, alleging that BAT's findings contradict tests conducted by other companies.


Further reading:


Content summary of the ELFBAR over-the-limit e-liquid incident in the UK.


British media reports obtaining BAT test report: Almost all disposable e-cigarette brands in the UK have excessive e-liquid levels.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden Threatens EU Tobacco Tax Deal as Nicotine Pouch Duty Dispute Looms Over November 9 Meeting
Sweden is expected to oppose a European Union proposal to raise minimum tobacco excise duties, Law360 reported on October 26, 2026, citing an EU official. A provisional Council agenda dated October 23 confirms that the tobacco taxation package is scheduled for discussion at the November 9 finance ministers' meeting, where member states will seek a general approach. The proposed reforms would raise minimum taxes on conventional tobacco products and establish EU-wide excise rules for vaping liquids, heated tobacco and nicotine pouches. Sweden supports harmonising tobacco taxation rules but objects to requiring nicotine pouches to bear the same minimum tax burden as certain smoking tobacco products. As EU indirect tax legislation requires unanimous Council approval, Swedish opposition could block the proposal in its current form.
Regulations
Oct.29
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea's Constitutional Court has upheld fixed taxes on nicotine-containing e-cigarette liquids based on solution volume, ruling that challenged provisions imposing KRW 370 per milliliter in individual consumption tax and KRW 628 per milliliter in tobacco consumption tax do not violate the Constitution. The cases stemmed from historical disputes involving importers that reported nicotine as being extracted from tobacco stems rather than leaves. South Korea has since broadened its tobacco definition to include synthetic nicotine, while current tax laws provide reduced rates for certain products not derived from tobacco.
Sep.18